The Oncology Institute Inc (TOI) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst ... [Yahoo! Finance]
The Oncology Institute, Inc. (TOI)
Company Research
Source: Yahoo! Finance
The Oncology Institute Inc ( NASDAQ:TOI ) achieved a 21.8% increase in overall revenue for the third quarter compared to the prior year, driven by significant growth in oral drug revenue. The company signed 13 new capitation contracts year-to-date, including its first in Oregon and a second in Florida, enhancing its service offerings and market reach. TOI achieved certification to begin radiopharmaceutical therapy in its California Radiation oncology practice, positioning it as one of the few community-based practices on the West Coast to offer this service. The company reported a 6% reduction in SG&A expenses compared to the prior year, reflecting successful cost optimization efforts. TOI's cash and cash equivalents increased by $1 million compared to Q2 2024, marking its first quarterly cash surplus of the year. The Oncology Institute Inc ( NASDAQ:TOI ) reported a net loss of $16.1 million for Q3 2024, although this was an improvement of $1.3 million compared to Q3 2023.
Show less
Read more
Impact Snapshot
Event Time:
TOI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TOI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TOI alerts
High impacting The Oncology Institute, Inc. news events
Weekly update
A roundup of the hottest topics
TOI
News
- The Oncology Institute Reports Third Quarter 2024 Financial ResultsGlobeNewswire
- The Oncology Institute Announces Certification to Administer Pluvicto Therapy in CaliforniaGlobeNewswire
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology Institute, Inc.Accesswire
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into The Oncology Institute, Inc.Accesswire
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The OncologyAccesswire
TOI
Earnings
- 8/13/24 - Miss
TOI
Sec Filings
- 11/18/24 - Form 4
- 11/18/24 - Form 4
- 11/18/24 - Form 4
- TOI's page on the SEC website